Detalhe da pesquisa
1.
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
Cell
; 181(4): 865-876.e12, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32353252
Mostrar mais
Texto completo
Documentos relacionados
2.
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.
Cell
; 178(6): 1313-1328.e13, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31491384
3.
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.
Cell
; 173(2): 417-429.e10, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625056
4.
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.
Immunity
; 56(11): 2621-2634.e6, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967533
5.
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
Immunity
; 56(8): 1927-1938.e8, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37506693
6.
The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity.
Cell
; 169(4): 679-692.e14, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475896
7.
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.
Nat Immunol
; 20(3): 362-372, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742080
8.
m6A modification controls the innate immune response to infection by targeting type I interferons.
Nat Immunol
; 20(2): 173-182, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559377
9.
Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.
Immunity
; 53(3): 685-696.e3, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783921
10.
A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet.
Nat Immunol
; 17(4): 422-32, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26950239
11.
Protective neutralizing influenza antibody response in the absence of T follicular helper cells.
Nat Immunol
; 17(12): 1447-1458, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27798619
12.
Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events.
Nat Immunol
; 17(2): 204-13, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26726811
13.
T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-γ on B Cells.
Immunity
; 50(5): 1172-1187.e7, 2019 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076359
14.
Lessons from lipids in the fight against influenza.
Cell
; 154(1): 22-3, 2013 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23827671
15.
A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection.
Cell
; 154(1): 197-212, 2013 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23827683
16.
Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation.
Cell
; 154(1): 213-27, 2013 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23827684
17.
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza.
Cell
; 153(1): 112-25, 2013 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23477864
18.
Targeting neuraminidase: the next frontier for broadly protective influenza vaccines.
Trends Immunol
; 45(1): 11-19, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38103991
19.
B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen.
Immunity
; 49(4): 695-708.e4, 2018 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291027
20.
Quadrivalent influenza nanoparticle vaccines induce broad protection.
Nature
; 592(7855): 623-628, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762730